FDA Inspection
Milbar Laboratories, Inc.Milbar Laboratories, Inc. – FDA Inspection, Oct 11, 2019
Record Details
This FDA Inspection record concerns Milbar Laboratories, Inc., with an inspection on October 11, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Milbar Laboratories, Inc.
- Inspection Date
- October 11, 2019
- Product Type
- Drugs
View Company Profile
ID · e0a3a4a1-c3b1-4951-8166-166204ed183d
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1107471
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Milbar Laboratories, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2024 | VAI | New England District Office | Drug Quality Assurance |
| January 2, 2024 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
| September 27, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 27, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Milbar Laboratories, Inc.
- FDA Inspection 1253807 - 2024-11-07
- FDA Inspection 1231023 - 2024-01-02
- FDA Inspection 1180954 - 2022-09-27
- FDA Inspection 1036724 - 2017-12-27
- FDA Inspection 971848 - 2016-05-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.